U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 48 results

Status:
US Approved Rx (2015)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Perindopril arginine is a stable L-arginine salt of perindopril. Perindopril, a pro-drug, is hydrolyzed to perindoprilat, which inhibits ACE in humans and in animals. It is indicated for the treatment of hypertension, heart failure and coronary arte...
Status:
US Approved Rx (2015)
First approved in 2007

Class (Stereo):
CHEMICAL (ACHIRAL)


[13N]Ammonia ([13N]NH3) is a useful 13N-labeled compound that has been developed as a positron emission tomography (PET) imaging agent for assessing regional blood flow in tissues. It is indicated for diagnostic PET imaging of the myocardium under re...
Status:
US Approved Rx (2014)
First approved in 1994

Class (Stereo):
CHEMICAL (ABSOLUTE)



Fludeoxyglucose F-18 is a positron emitting radiopharmaceutical that is used for diagnostic purposes in conjunction with positron emission tomography (PET) imaging.
Status:
US Approved Rx (1999)
First approved in 1991

Class (Stereo):
CHEMICAL (ACHIRAL)



Ticlopidine (trade name Ticlid) is an antiplatelet drug in the thienopyridine family which is an adenosine diphosphate (ADP) receptor inhibitor. Ticlopidine is a prodrug that is metabolized to an as yet undetermined metabolite that acts as a platelet...
Status:
US Approved Rx (1989)
First approved in 1989

Class (Stereo):
CHEMICAL (ACHIRAL)


Rubidium Rb-82 is a radioactive isotope of rubidium. It is widely used for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with sus...
Status:
US Approved Rx (2015)
First approved in 1987

Class (Stereo):
CHEMICAL (RACEMIC)



Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. Experimental data suggest that amlodipine binds...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)



Apabetalone (RVX-208) is a small molecule BET bromodomain inhibitor selective for BRD4-BD2 undergoing clinical development as a potential therapy to enhance ApoA-I production and treat atherosclerosis and prevent cardiovascular disease events. Apabet...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)



Atopaxar, also known as E 5555 is a novel reversible protease-activated receptor-1 (PAR-1) thrombin receptor antagonist. The inhibition of thrombin-mediated platelet activation by means of protease-activated receptor-1 inhibitors represents an attra...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Terutroban (S18886), a specific thromboxane A2 receptor antagonist, which improves endothelial function and has an antiatherosclerotic effect. The compound is under development by Servier for the potential treatment of cardiovascular diseases and cor...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)



Varespladib (LY315920; A-001) is a potent and selective inhibitor of IIa, V, and X isoforms of human non-pancreatic secretory phospholipase A2 with nM IC50. The molecule acts as an anti-inflammatory agent by disrupting the first step of the arachido...